Verxant Sc Injection Icin Liyofilize Powder Iceren Vial

Description

This exceptional injection proves its efficacy in managing the following inflammatory diseases:

1. Plaque Psoriasis

Verxant SC takes center stage in combatting moderate to severe plaque psoriasis, an inflammatory skin disease. When other medications fall short, Verxant SC may be prescribed to mitigate the signs and symptoms of plaque psoriasis, ushering relief.

2. Psoriatic Arthritis

For active psoriatic arthritis, a condition that inflames the joints and frequently co-occurs with psoriasis, Verxant SC emerges as an ally. In cases where alternative treatments prove insufficient, Verxant SC may be recommended to diminish the signs and symptoms of active psoriatic arthritis, enhance physical functionality, and impede joint damage.

3. Ankylosing Spondylitis

Verxant SC takes charge against active ankylosing spondylitis, an inflammatory ailment primarily affecting the spine’s joints. When conventional medications falter, Verxant SC steps in to alleviate the disease’s manifestations, mitigate inflammation, and improve physical well-being.

Packaging

Verxant SC Injection exudes convenience and reliability, encapsulated in a package containing one vial of lyophilized powder for reconstitution.

 Side Effects

As Verxant SC Injection harnesses the therapeutic potential of sekukinumab, an immunosuppressant known for reducing inflammation-causing chemical substances, awareness of possible side effects is essential.

Common Side Effects

Frequently observed side effects of sekukinumab include:

• Upper respiratory infections
• Cold symptoms
• Diarrhea

Serious Side Effects

Verxant SC Injection may heighten the risk of severe side effects such as infections. By reducing immune system efficacy against infections, it may elevate the risk of infections. To ascertain tuberculosis (TB) risk, your healthcare provider should conduct an assessment before and during Verxant SC Injection treatment, potentially prescribing TB medication if needed.

In case of any signs of infection while utilizing sekukinumab, such as fever, chills, muscle aches, cough, weight loss, blood in phlegm, infected skin sores, diarrhea or stomach pain, pain or burning during urination, or increased frequency of urination, immediate contact with your healthcare provider is vital.

This list does not encompass all possible side effects of sekukinumab. Should you experience other side effects or have concerns about the medication, consult your healthcare provider for expert guidance.

Optimal Administration Frequency

The administration frequency of Verxant SC Injection hinges on the specific condition under treatment, featuring subcutaneous (SC) injection with or without a loading dose.

For Plaque Psoriasis

The recommended dose is 300 mg SC at weeks 0, 1, 2, 3, and 4, followed by 300 mg every 4 weeks thereafter. Some patients may find a dose of 150 mg acceptable.

For Psoriatic Arthritis

The recommended dose is 150 mg SC at weeks 0, 1, 2, 3, and 4, followed by 150 mg every 4 weeks thereafter, with or without a loading dose.

For Ankylosing Spondylitis

The recommended dose is 150 mg SC at weeks 0, 1, 2, 3, and 4, followed by 150 mg every 4 weeks thereafter, with or without a loading dose. If active ankylosing spondylitis persists, the dose may be increased to 300 mg every 4 weeks.

Compliance with the dosing instructions provided by your healthcare provider is crucial. For clarifications on Verxant SC Injection administration frequency, reach out to your healthcare provider for personalized counsel.